~~<i id='40EA3EF3A6'><strike id='40EA3EF3A6'><tt id='40EA3EF3A6'><pre id='40EA3EF3A6'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

fashion

author：knowledge 2025-09-30 00:50:43 - browse：5

The FDA building -- First Opinion coverage from STAT — Adobe

WASHINGTON — The Food and Drug Administration’s top cancer drug regulator doesn’t always ask for permission before taking on big initiatives.

Richard Pazdur, director of the FDA Oncology Center of Excellence, hates bureaucracy. It stifles his ideas for getting treatments to cancer patients faster — of which there are many.

To cut through that bureaucracy, Pazdur has a trick: “Don’t tell anybody,” he said to laughter at a meeting of the advocacy group Friends of Cancer Research Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Reporting on presidential health from Reagan to Trump and Biden

explore

focus

leisure time

Wikipedia

entertainment

leisure time

TomDiLengeofFlagshipPioneering(left)withU.S.CongressmanRajaKrishnamoorthiofIllinoisata"techfair"desi

WSS

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

The new HIV moral panic

Opioid cravings were reduced by anti

Argenx drug significantly slows progression of nerve disorder

Mike Pence clashes with Tucker Carlson in Iowa

hotspot

fashion

explore

Supreme Court strikes down use of affirmative action

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

The high cost of giving birth even with insurance

Woman gored by Bison at Yellowstone

Affirmative action in medical school literally saved lives

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Trump demands the U.S. pay no more for drugs than other countries … again

Argenx drug significantly slows progression of nerve disorder

Hollywood unions extend contract negotiations for actors

A new drug could help frostbite victims avoid its ravages

focus

New study raises questions about niacin and heart health

Reporting on presidential health from Reagan to Trump and Biden

Mike Pence clashes with Tucker Carlson in Iowa

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

As AI regulations shape up, health tech startups beg for clarity

Europe sees delivery challenges ahead on Alzheimer's therapies

leisure time

Wikipedia

entertainment

leisure time